title: Holistic Impact of Closed-Loop Technology on People With Type 1 Diabetes.
authors: National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Southampton, UK A.J.Young@southampton.ac.uk.
authors: Amanda J
authors: AJ
authors: Young
authors: Wellcome Trust/MRC Institute of Metabolic Science, Cambridge, UK.
authors: Hood
authors: H
authors: Thabit
authors: Department of Human Metabolism, Sheffield, UK.
authors: Simon R
authors: SR
authors: Heller
authors: Wellcome Trust/MRC Institute of Metabolic Science, Cambridge, UK.
authors: Mark L
authors: ML
authors: Evans
authors: King's College London, London, UK.
authors: Stephanie A
authors: SA
authors: Amiel
authors: Wellcome Trust/MRC Institute of Metabolic Science, Cambridge, UK.
authors: Roman
authors: R
authors: Hovorka
authors: Human Development and Health Academic Unit, Southampton, UK.
authors: Katharine D
authors: KD
authors: Barnard
mesh_terms: D000328:Adult; D000465:Algorithms; D001786:Blood Glucose / Q000032:analysis; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000523:psychology*; D005260:Female; D006801:Humans; D015918:Infusion Pumps, Implantable; D007328:Insulin / Q000008:administration & dosage; D007332:Insulin Infusion Systems; D008297:Male; D018670:Monitoring, Ambulatory; D019397:Pancreas, Artificial / Q000523:psychology*; D016896:Treatment Outcome
chemical_list: D001786:Blood Glucose; D007328:Insulin
keywords: HbA1c; artificial pancreas; closed-loop technology; continuous glucose monitor; psychosocial impact